Showing 1 posts of 1 posts found.
US biopharma firm Questcor has signed a deal to acquire Canadian active pharmaceutical ingredient (API) manufacturer BioVectra for an upfront …
PlaqueTec coronary disease trial reaches 100 patients across eight NHS centres
PhaSER secures $2.7m Gates Foundation renewal for neglected disease drug research
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
Europa Biosite enters Czech market with acquisition of diagnostics distributor